Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposure
P Mease, A Deodhar, R Fleischmann, J Wollenhaupt, D Gladman, P Leszczyński, P Vitek, A Turkiewicz, M Khraishi, O FitzGerald, R Landewé, M de Longueville, B Hoepken, L Peterson, D van der Heijde
RMD Open Jun 2015, 1 (1) e000119; DOI: 10.1136/rmdopen-2015-000119